An Efficacy Study of Minon Whole Body Moisturizing Milk in Elderly People Aged 75 Years and Older

An Efficacy Study of Minon Whole Body Moisturizing Milk in Elderly People Aged 75 Years and Older - An Efficacy Study of Minon Whole Body Moisturizing Milk in Elderly People Aged 75 Years and Older

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000059517

Enrollment

Registered

2025-10-27

Start date

2025-11-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Xerosis

Interventions

Apply this drug to the lower legs twice daily (morning and evening) for 4 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Individuals who express willingness to participate in the study, understand the explanation, and can provide written informed consent. 2. Japanese men and women aged 75 years or older. 3. Individuals who are aware of dryness of the skin on the lower legs. 4. Individuals who can visit Infoward Co., Ltd. Ebisu Skin Research Center (Shibuya-ku, Tokyo) without the need for special assistance or support. 5. Individuals who do not require special assistance or support for understanding informed consent, giving consent, and withdrawing consent (i.e., those who do not need a legal representative). 6. Individuals who are able to fill out documents such as consent forms, questionnaires, and usage diaries.

Exclusion criteria

Exclusion criteria: 1. Individuals diagnosed with type 1 or type 2 diabetes. 2. Individuals diagnosed with malignant tumors. 3. Individuals diagnosed with skin diseases (such as atopic dermatitis, acne vulgaris, psoriasis, etc.). 4. Patients undergoing artificial dialysis. 5. Individuals diagnosed with liver diseases. 6. Individuals infected with infectious diseases (HBV/HCV/HIV/syphilis). 7. Individuals currently taking steroid preparations or immunosuppressants. 8. Individuals who have regularly used pharmaceuticals, quasi-drugs, cosmetics, etc. for moisturizing purposes on the lower legs within 4 weeks prior to the start of the study (temporary use is permitted). 9. Individuals who consume alcohol excessively. 10. Individuals currently participating or who have participated within the past 3 months in clinical trials, usage surveys, or product monitoring related to investigational drugs, cosmetics, pharmaceuticals, etc. 11. Individuals who have experienced severe allergic reactions in the past due to the use of topical medications, cosmetics, quasi-drugs, or other products. 12. Individuals employed by pharmaceutical manufacturers or cosmetics companies, including the subjects themselves or their family members. 13. Any other individuals deemed unsuitable by the study physician.

Design outcomes

Primary

Measure	Time frame
Efficacy Evaluation	—

Countries

Japan

Contacts

Public ContactKanako Sakurai

Infoward Co., Ltd. Ebisu Skin Research Center

sakurai@inforward.co.jp03-5793-8712

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026